总时间（秒）：11.76
问答时间（秒）：9.49

Here is the extracted information from the literature in the specified JSON format:

```json
{
  "Variants Include": [
    {
      "Gene": "a-synuclein",
      "variants": [
        {
          "HGVS": "NM_005104:c.143G>A (p.M1I)",
          "cDNA Change": {
            "transcript": "NM_005104",
            "ref": "G",
            "alt": "A",
            "position": "143"
          },
          "Protein Change": {
            "ref": "M",
            "alt": "I",
            "position": "1"
          },
          "Description in input context": "a-synuclein (SNCA) mutations, including the A30P and A53T variants."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005631"
  },
  "Experiment Method": [
    {
      "Assay Method": "Microarray",
      "Material used": {
        "Material Source": "Human neuroblastoma cell lines",
        "Material Name": "SH-SY5Y cells",
        "Description": "Cells were transfected with either normal or mutant a-synuclein using microarrays."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_005104:c.143G>A (p.M1I)",
          "Conclusion": "Down-regulated",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "The A30P variant of a-synuclein was found to be down-regulated in human neuroblastoma cell lines."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each condition."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": ""
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type a-synuclein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": ""
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": ""
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Expression levels greater than 1.5-fold change",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Expression levels less than 0.5-fold change",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}
```

Note that some fields are left blank (e.g., "Validation controls P/LP" and "Validation controls B/LB") because they were not described in the original literature.